MAESTRO, NCT01746979 / 2012-002957-42: Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma |
|
|
| Completed | 3 | 693 | US, Europe | TH-302, Gemcitabine, Placebo (5 percent dextrose - D5W) | Threshold Pharmaceuticals | Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma | 02/16 | 05/16 | | |
